Willingness to pay for a quality-adjusted life year: Implications for societal health care resource allocation

被引:165
作者
King, JT
Tsevat, J
Lave, JR
Roberts, MS
机构
[1] VA Connecticut Healthcare Syst, Neurosurg Sect, West Haven, CT 06516 USA
[2] Yale Univ, Dept Neurosurg, New Haven, CT USA
[3] Univ Cincinnati, Dept Internal Med, Inst Hlth Policy & Hlth Serv Res, Med Ctr, Cincinnati, OH USA
[4] Univ Cincinnati, Ctr Clin Effectiveness, Inst Hlth Policy & Hlth Serv Res, Med Ctr, Cincinnati, OH USA
[5] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA
[6] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA
[7] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA USA
[8] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[9] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA
关键词
cost-effectiveness analysis; preferences; QALYs; utility; willingness to pay;
D O I
10.1177/0272989X05282640
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background. Health-state preferences can be combined with willingness-to-pay (WTP) data to calculate WTP per quality-adjusted life year (QALY). The WTP/QALY ratios provide insight into societal valuations of expenditures for medical interventions. Methods. The authors measured preferences for current health in 3 patient populations (N = 391) using standard gamble, time trade-off, visual analog scale, and WTP then they calculated WTP/QALY ratios. The ratios were compared with several proposed cost/QALY cost-effectiveness ratio thresholds, the value-of-life literature, and with WTP/QALY ratios derived from published preference research. Results. Mean WTP/QALY ratios ranged from $12,500 to $32,200 (2003 $US). All values were below most published cost-effectiveness ratio thresholds, below the ratio from a prototypic medical treatment covered by Medicare (i.e., renal dialysis), and below ratios from the value-of-life literature, The WTP/QALY ratios were similar to those calculated from published preference data for patients with symptomatic menopause, dentofacial deformities, asthma, or dermatologic disorders. Conclusions. WTP/QALY ratios calculated using preference data collected from diverse populations are lower than most proposed thresholds for determining what is "cost-effective," Current proposed cost-effectiveness ratio thresholds may overestimate the willingness of society to pay for medical interventions.
引用
收藏
页码:667 / 677
页数:11
相关论文
共 41 条
[1]  
[Anonymous], SF 36 PHYS MENT HLTH
[2]  
[Anonymous], CONS PRIC IND ALL UR
[3]  
Arias E, 2002, NATL VITAL STAT REPO, V51, P7
[4]   Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma [J].
Blumenschein, K ;
Johannesson, M .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 80 (02) :189-194
[5]   WHOSE UTILITIES FOR DECISION-ANALYSIS [J].
BOYD, NF ;
SUTHERLAND, HJ ;
HEASMAN, KZ ;
TRITCHLER, DL ;
CUMMINGS, BJ .
MEDICAL DECISION MAKING, 1990, 10 (01) :58-67
[6]   A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip [J].
Chang, RW ;
Pellissier, JM ;
Hazen, GB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11) :858-865
[7]  
Cunningham SJ, 2000, COMMUNITY DENT HLTH, V17, P92
[8]  
DENARVASWALT C, 2003, INCOME US 2002 CURRE
[9]  
Diener A, 1998, HEALTH ECON, V7, P313, DOI 10.1002/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.0.CO
[10]  
2-B